Home » Topics » Regulatory

Regulatory
RSS

Prolia obtains marketing authorization in E.U.

May 31, 2010

FDA approves Vimovo delayed-release tablets for arthritis patients

May 3, 2010

Dendreon receives FDA approval for Provenge for castrate-resistant prostate cancer

April 30, 2010

Takeda obtains five NDA approvals in Japan

April 20, 2010

Diquas ophthalmic solution approved in Japan for dry eye treatment

April 19, 2010

EMA approves combination of Xeloda and oxaliplatin for adjuvant treatment of early colon cancer

March 30, 2010

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

March 24, 2010

FDA approves Somaxon's Silenor for treatment of insomnia

March 19, 2010

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...